IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.228
NA - Nord America 4.585
AS - Asia 813
AF - Africa 17
SA - Sud America 14
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.459
IE - Irlanda 1.731
UA - Ucraina 754
IT - Italia 693
GB - Regno Unito 613
DE - Germania 446
FR - Francia 372
CN - Cina 355
SG - Singapore 245
SE - Svezia 204
FI - Finlandia 200
GR - Grecia 134
TR - Turchia 120
CA - Canada 118
VN - Vietnam 54
PL - Polonia 27
BE - Belgio 24
KR - Corea 16
SC - Seychelles 13
CZ - Repubblica Ceca 10
JP - Giappone 8
MX - Messico 8
NL - Olanda 7
NZ - Nuova Zelanda 6
BR - Brasile 5
EU - Europa 5
IR - Iran 5
ES - Italia 4
PE - Perù 4
AU - Australia 3
PK - Pakistan 3
CL - Cile 2
HK - Hong Kong 2
IN - India 2
MK - Macedonia 2
RS - Serbia 2
UG - Uganda 2
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
CO - Colombia 1
IL - Israele 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 10.671
Salva come PNG Salva come JPEG
Città #
Dublin 1.724
Jacksonville 1.174
Chandler 806
Princeton 245
Medford 216
New York 151
Singapore 144
Caserta 143
Ann Arbor 142
Roxbury 142
Boardman 140
Bremen 134
San Mateo 125
Elora 98
Wilmington 97
Naples 84
Woodbridge 74
Beijing 62
Nanjing 61
Dong Ket 52
Cambridge 51
Des Moines 50
Napoli 46
Jinan 35
Mountain View 29
Ashburn 27
Kraków 26
Brussels 23
Houston 20
Norwalk 19
Milan 16
Düsseldorf 15
Helsinki 15
Tianjin 15
Aiello Del Sabato 14
Nanchang 13
Shenyang 13
Auburn Hills 12
Hangzhou 11
Lanzhou 11
Ottawa 11
Brno 10
Los Angeles 10
Rome 10
Taizhou 10
Zhengzhou 10
Aversa 9
Changsha 8
Munich 8
Ningbo 8
Redwood City 8
Guangzhou 7
Jiaxing 7
Kunming 7
Lappeenranta 7
Hebei 6
Parma 6
Salerno 6
Boydton 5
Changchun 5
Haikou 5
Hanover 5
Marigliano 5
Sennori 5
Shanghai 5
Taiyuan 5
Benevento 4
Casoria 4
Hefei 4
Lima 4
London 4
Seattle 4
Somma Vesuviana 4
Trieste 4
Amsterdam 3
Arzignano 3
Atlanta 3
Avellino 3
Battipaglia 3
Calvizzano 3
Canicattì 3
Cattolica 3
Ercolano 3
Gunzenhausen 3
Jesi 3
Mugnano Di Napoli 3
Pomezia 3
Potenza 3
San Nicola la Strada 3
Toronto 3
Viareggio 3
Xiangfen 3
Andover 2
Athens 2
Bagnoli Irpino 2
Bari 2
Berlin 2
Catania 2
Fairfield 2
Ferrara 2
Totale 6.565
Salva come PNG Salva come JPEG
Nome #
ONCOLOGIA MEDICA 145
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 101
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 85
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 85
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 82
Predictive biomarkers along gastric cancer pathogenetic pathways 79
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 79
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 76
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 75
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 74
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 73
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 72
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 72
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 71
TRASTUZUMAB RESISTANCE IN BREAST CANCER 71
Clinical management of advanced gastric cancer: Role of new molecular drugs. 70
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 70
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 69
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 68
Farmacogenomica e cancro colorettale 66
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 65
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 65
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 65
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 64
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 63
Treatment of gastric cancer. 63
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 63
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 63
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 62
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 61
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 61
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 61
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 60
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 60
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 59
Chemoradiotherapy as adjuvant treatment of gastric cancer 59
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 59
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 58
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 58
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 58
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 58
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 57
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 57
Cardiotossicità da antracicline: attualità e prospettive 57
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 57
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 57
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 57
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 56
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 56
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 56
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 56
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 55
Ventricular repolarization time indexes following anthracycline treatment 55
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 55
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 55
Post- operative xelox and chemoradiation in stage III-IV radically resected gastric cancer patients: preliminary results of a pilot study. 55
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 55
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 55
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 54
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 54
Integrated therapy in localized gastric cancer: targeted and tailored approach. 54
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group 54
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 54
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 54
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 54
Il linfoma primitivo della parotide: una localizzazione infrequente 54
Il trattamento delle neoplasie polmonari nell’anziano 54
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 53
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 53
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 53
Adult Wilms' tumor: a case report 53
Targeting EGFR in Pancreatic Cancer Treatment. 53
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial 53
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. 52
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 52
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines. 52
Integrated therapy in localized gastric cancer: targeted and tailored approach. Letter to the editor 52
Neo-adjuvant and adjuvant chemotherapy of gastric cancer 52
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: A phase II study 52
Carcinoma dell'esofago 52
Insulin-like growth factor-1 bioactivity plays a prosurvival role in older participants 51
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study 51
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 51
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 51
Cetuximab in the treatment of colorectal cancer. 51
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 51
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 51
Sequential treatment with pazopanib and everolimus in metastatic renal cell carcinoma 51
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 51
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 50
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 50
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 50
Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study. 50
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 50
Malignant transformation in non-recurrent peritoneal cystic mesothelioma Our experience and review of the literature 50
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 50
Preoperative chemo-radiotherapy for carcinoma of the esophagus 49
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 49
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 49
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 48
Totale 5.991
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.393 246 219 35 22 196 29 266 101 134 73 55 17
2020/20211.763 165 19 193 85 342 13 234 186 39 217 171 99
2021/20221.456 134 10 16 24 528 8 30 48 51 61 125 421
2022/20233.338 432 61 45 262 364 257 15 194 1.592 14 56 46
2023/20241.317 107 36 59 119 446 168 16 31 16 19 92 208
2024/202526 26 0 0 0 0 0 0 0 0 0 0 0
Totale 11.213